Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

ENDRA Life Sciences (NDRA) EBT Margin (2016 - 2018)

ENDRA Life Sciences has reported EBT Margin over the past 3 years, most recently at 45761.31% for Q1 2018.

  • Quarterly EBT Margin changed N/A to 45761.31% in Q1 2018 from the year-ago period, while the trailing twelve-month figure was 158669.6% through Dec 2018, down 15714041.0% year-over-year, with the annual reading at 158669.6% for FY2018, 15714041.0% down from the prior year.
  • EBT Margin was 45761.31% for Q1 2018 at ENDRA Life Sciences, down from 33498.39% in the prior quarter.
  • Over five years, EBT Margin peaked at 133.61% in Q4 2016 and troughed at 45761.31% in Q1 2018.
  • The 3-year median for EBT Margin is 2478.35% (2017), against an average of 16437.67%.
  • The largest YoY upside for EBT Margin was -3336478bps in 2017 against a maximum downside of -3336478bps in 2017.
  • A 3-year view of EBT Margin shows it stood at 133.61% in 2016, then plummeted by -24971bps to 33498.39% in 2017, then plummeted by -37bps to 45761.31% in 2018.
  • Per Business Quant, the three most recent readings for NDRA's EBT Margin are 45761.31% (Q1 2018), 33498.39% (Q4 2017), and 316.69% (Q3 2017).